核医学诊疗中患者内照射的研究进展  

Internal irradiation of patients in the diagnosis and treatment of nuclear medicine

作　　者：何鑫雨 尚兵[1] 姜晓燕[1] 丁库克[1] He Xinyu;Shang Bing;Jiang Xiaoyan;Ding Kuke(Department of Radioecology,National Institute for Radiological Protection,Chinese Center for Disease Control and Prevention,Beijing 100088,China)

机构地区：[1]中国疾病预防控制中心辐射防护与核安全医学所放射生态学研究室,北京100088

出　　处：《国际放射医学核医学杂志》2021年第8期539-544,共6页International Journal of Radiation Medicine and Nuclear Medicine

基　　金：国家自然科学基金(31770907)。

摘　　要：在核医学诊疗中,放射性核素不仅照射患者体内的靶器官,同时对其他正常的组织和器官也会产生照射。笔者介绍了国内外与核医学有关的人体辐射剂量模型发展趋势,重点针对核医学常用的3种放射性核素(^(18)F、^(99)Tc^(m)、^(131)I)标记的显像剂导致患者内照射剂量及其影响因素进行综述,为研究核医学诊疗患者内照射剂量与辐射防护工作提供参考。In the diagnosis and treatment of nuclear medicine,radionuclides irradiate not only the target organs in the patient,but also other normal tissues and organs.This paper introduces the development trend of human radiation dose models at home and abroad,and reviewed the internal doses of three radionuclide(^(18)F,^(99)Tc^(m),^(131)I)labeled imaging agents commonly used in nuclear medicine and its influencing factors.It provides a reference for the study of radiation dose and radiation protection in nuclear medicine diagnosis and treatment.

关 键 词：核医学 辐射防护 人体模型 内照射 有效剂量 

分 类 号：R817[医药卫生—影像医学与核医学]